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Mechanism of regulation of Na1 transport by angiotensin II tubule (RPT) has been reported repeatedly [5, 6]. These
in primary renal cells. effects of Ang II have been largely attributed to the
Background. Angiotensin II (Ang II) has a dose-dependent, ability of Ang II to modulate the activity of the apicalbiphasic effect on the activity of the Na1/H1 antiport system
Na1/H1 antiport system in the RPT. While Ang II atin the renal proximal tubule (RPT). The aim of the present
low concentrations is stimulatory to the Na1/H1 antiportstudy was to further delineate the signaling pathways involved
in Ang II action. system, Ang II at high concentrations causes inhibition
Methods. To examine Ang II signaling, 22Na1 uptake studies of Na1/H1 antiport system activity. Ang II initiates its
were conducted with a primary rabbit RPT cell culture system.
actions by binding to specific receptors localized on bothThe activation of phospholipase A2 (PLA2) was assessed by
the apical and the basolateral surface of RPT cells [7].measuring the release of [3H]-arachidonic acid (AA), and
changes in intracellular calcium levels were determined by Subsequently, a number of different signaling pathways
means of confocal microscopy. are initiated. For example, when Ang II is applied at
Results. Low dosages of Ang II (,10210 mol/L) stimulated low concentrations, signaling pathways are initiated thatNa1 uptake, whereas high dosages of Ang II (.10210 mol/L)
cause the inhibition of cAMP-dependent protein kinaseinhibited Na1 uptake. Ang II (.10210 mol/L) also caused an
and the activation of protein kinase C [8–10].increase in AA release associated with an increase in intracellu-
lar calcium. Not only did exogenous AA inhibit Na1 uptake, Ang II at high dosages (1029 to 1026 mol/L) has been
but two PLA2 inhibitors (mepacrine and AACOCF3) blocked proposed to affect transport through the activation of
the Ang II-mediated inhibition of Na1 uptake. However, the
phospholipase A2 (PLA2). Following PLA2 activation,cytochrome P450-dependent epoxygenase inhibitor econazole
membrane-bound arachidonic acid (AA) is releasedalso blocked the Ang II-induced inhibition of Na1 uptake.
Inhibition of Na1 uptake was obtained by the metabolic prod- [8, 11, 12], and the released AA is then metabolized
uct of the epoxygenase 5,6-EET. In turn, the inhibitory effect via a cytochrome P450-dependent epoxygenase pathway
of 5,6-EET was blocked by indomethacin. [6, 10, 13]. 5,6-Epoxyeicosatrienoic acid (5,6-EET), anConclusions. The results indicate the involvement of a cal-
AA metabolite emerging from this cytochrome P450-cium-dependent PLA2 in mediating the inhibitory effect of Ang
dependent epoxygenase pathway, has been proposed toII on Na1 uptake. The AA, which is released following PLA2
activation, acts indirectly, through its own metabolism, via a be a mediator in the Ang II-induced inhibition of Na1/H1
cytochrome P450 epoxygenase pathway and ultimately cyclo- antiport system activity [8]. The roles of these different
oxygenase itself. signaling pathways in mediating the effects of Ang II on
the Na1/H1 antiport system have not yet been clearly
elucidated.
Angiotensin II (Ang II) is widely recognized as an Further studies would benefit by using a RPT cell
important regulator of renal sodium excretion [1–4]. A culture system, which retains not only the transport re-
dose-dependent, biphasic effect of Ang II on NaCl, bicar- sponses to Ang II, but also possesses intact Ang II signal-
bonate, and water reabsorption by the renal proximal
ing mechanisms. Such a renal cell culture system is im-
portant because of its extended viability, as compared
with isolated renal tissue, which permits detailed mecha-Key words: renal proximal tubule, Na1/H1 antiporter, arachidonic
acid, cell signaling, 5,6-epoxyeicosatrienoic acid. nistic studies under a steady-state condition. However,
one problem with some established renal cell lines is the
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arginine vasopressin (AVP)-sensitive adenylate cyclase, phosphate-buffered saline (PBS) and subsequently with
a 50:50 mixture of Dulbecco’s modified Eagle’s mediumrather than the parathyroid hormone (PTH) respon-
siveness typical of the RPT [16]. Renal cell lines that are (DME/F12) containing 0.5% iron oxide (wt/vol) until
the kidney turned gray-black in color. Renal cortical slicesimmortalized by viruses and oncogenes may have similar
problems, as exemplified by the repression of membrane were prepared and then homogenized with four strokes
of a sterile glass homogenizer (type A pestle). The ho-expression of AVP receptors in rabbit renal collecting
duct cells transformed with SV40 [17]. mogenate was poured first through a 253 mm and then
a 83 mm mesh filter. Tubules and glomeruli on top ofThe primary rabbit RPT cell culture system that was
used in this report retains in vitro the differentiated pheno- the 83 mm filter were transferred into sterile DME/F12
medium containing a magnetic stirring bar. Glomerulitype typical of the RPT, which includes a polarized mor-
phology [18], apical membrane proteins (leucine amino- (containing iron oxide) were removed with the mag-
netic stirring bar. The remaining proximal tubules werepeptidase and g glutamyl transpeptidase) [19], distinctive
proximal tubule transport systems (the Na1/glucose co- washed by centrifugation and incubated for two minutes
at 238C in DME/F12 containing 60 mg/mL collagenasetransport system [19] and the p-aminohippurate (PAH)
transport system [20]), as well as hormone responses. As (class IV) and 0.025% soybean trypsin inhibitor. The
dissociated tubules were then washed by centrifugation,observed with RPT cells in vivo, the primary RPT cell
cultures have a PTH-sensitive adenylate cyclase [19]. In resuspended in DME/F12 containing three growth sup-
plements (5 mg/mL bovine insulin, 5 mg/mL human trans-the renal cortex, not only is a responsiveness to PTH
observed, but in addition, AVP has a similar effect on ferrin, and 5 3 1028 mol/L hydrocortisone) and trans-
ferred into 35 mm tissue culture dishes. The primarycAMP production, due to a small number of distal tubule
cells in this preparation [19]. However, the primary RPTs RPT cell cultures were maintained at 378C in a 5% CO2-
humidified environment. The medium was changed onedo not similarly respond to AVP by producing cAMP,
indicating this culture system is highly purified with re- day after plating and every two days thereafter.
spect to RPT cells [19]. RPT cells respond to physiologic
Ang II binding assaylevels of insulin by the inhibition of their phosphoenol-
pyruvate carboxykinase (PEPCK) activity [21], suggesting The Ang II binding assays were performed as described
by Becker and Harris [23]. To summarize, confluentthe presence of insulin receptors. Growth in response to
17b estradiol is indicative of the presence of estrogen monolayers of primary RPT cultures were washed twice
with ice-cold PBS containing 0.1% albumin (PBS-A).receptors in the primary RPT cell cultures [22].
Our study was concerned with determining whether Primary RPT cultures were incubated for 30 minutes at
378C in PBS-A containing 125I-Ang II (0.1 pmol/L), unla-regulation of the activity of the Na1/H1 antiport system
by Ang II in primary rabbit RPT cell cultures occurs beled Ang II (10211 to 1029 mol/L), and either losartan,
PD123319, or no further addition. The cells were thenthrough mechanisms similar to those reported with intact
rat kidney proximal tubules. The results of these studies washed three times with ice-cold PBS-A and lyzed with
0.05 mol/L NaOH. The radioactivity in a portion of theindicate that, as in intact RPTs, there are biphasic effects
of Ang II on sodium transport with low concentrations cell lysate was determined in a g counter (Packard 5400,
Downers Grove, IL, USA), and the remainder of lysatestimulating and high concentrations inhibiting transport.
The mechanisms underlying the effects of high concen- was used for protein determination [24]. The 125I-Ang II
bound in each sample was standardized with respect totrations of Ang II on sodium transport are examined in
detail. The effects of high concentrations of Ang II ap- protein. Average binding determinations were calcu-
lated. Specific binding was calculated as total bindingpear to be mediated by means of a PLA2-dependent
step with the possible activation of cytochrome P450 minus nonspecific binding in the presence of excess unla-
beled Ang II (1026 mol/L).epoxygenase, resulting in the production of EETs and
their secondary metabolites. The potential involvement
Na1 uptake studiesof a calcium-mediated pathway is also considered.
The confluent monolayers were first preincubated with
Ang II for four hours and with 5 3 1025 mol/L ouabain
METHODS
for three hours prior to the 22Na1 uptake studies. Uptake
Preparation of primary RPT cultures experiments were then conducted as described by Rind-
ler, Taub, and Saier [25]. To summarize, uptake bufferPrimary cultures were prepared by a modification of
the method of Chung et al [19]. Each experimental study was added to the apical compartment, and the mono-
layers were incubated at 378C for 30 minutes in uptakewas conducted with a single primary culture set prepared
from an individual kidney obtained from a male New buffer (which contained 1 mmol/L CaCl2, 1 mmol/L
MgCl2, 10 mmol/L Tris, pH 7.4, 140 mmol/L cholineZealand White rabbit (1.5 to 2.0 kg). To summarize,
each kidney was perfused via the renal artery, first with chloride, 140 mmol/L NaCl, 0.25 mCi/mL 22Na1, 5 3 1025
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mol/L ouabain, and Ang II where appropriate). In the each condition were calculated and compared percent-
age-wise to the total level of [3H]-AA present (that is, thepresence of ouabain, intracellular 22Na1 levels were ele-
total released radioactivity plus the total cell-associatedvated, presumably because of a decrease in the efflux of
radioactivity at the end of the stimulation period).Na1 from the cells via the Na,K-ATPase. At the end
of the incubation period, the monolayers were gently
Measurement of [Ca21]i by confocal microscopywashed three times with ice-cold 100 mmol/L Tris-HCl,
Fluo-3/AM (excitation, 485 nm; emission, 530 nm) waspH 7.4, and solubilized in 1 mL of 0.1% sodium dodecyl
initially dissolved in dimethylsulfoxide and stored atsulfate (SDS). To determine the intracellular 22Na1, 900
2208C. The confluent RPT monolayers in 35 mm culturemL of each sample were removed and counted in a liquid
dishes were first rinsed twice with bath solution (140scintillation counter (Beckman Co., Palo Alto, CA, USA),
mmol/L NaCl, 5 mmol/L KCl, 1 mmol/L CaCl2, 0.5and the remainder of each sample was used for protein
mmol/L MgCl2, 10 mmol/L glucose, 5.5 mmol/L HEPES,determination. The radioactive counts in each sample
pH 7.4), incubated in bath solution containing 3 mmol/Lwere then normalized with respect to protein and were
Fluo-3/AM with 5% CO2/95% O2 at 378C for one hour,corrected for zero-time uptake. Averages were made
rinsed twice again with bath solution, mounted on a perfu-of triplicate determinations. Under the conditions used,
sion chamber, and scanned by means of confocal micros-1023 mol/L amiloride significantly decreased Na1 uptake
copy (3400; Leica TCS 4D). During the scanning, the(59 6 4% compared with control), suggesting the pres-
cells were treated with Ang II at dosages ranging fromence of an amiloride-sensitive Na1/H1 antiport system
1026 to 10212 mol/L. In the experiments using EGTA, the(most likely either NHE2 or NHE3, which are both less
monolayers were preincubated in DME/F12 containingsensitive to amiloride than NHE1). When 10211 mol/L
EGTA (1 mmol/L) for three hours prior to their one-Ang II and 1023 mol/L amiloride were added together
hour incubation in bath solution. A23187 (2.5 mmol/L)to the primary RPT cultures, Na1 uptake was similar to
and dimethylsulfoxide (30 mmol/L) were used as positivethat of 1023 mol/L amiloride alone (data not shown).
and negative controls, respectively. Data were analyzed
by Microsoft Excel.[3H]-arachidonic acid release
[3H]-arachidonic acid release experiments were per- Chemicals
formed by a modification of the method of Xing, Tao,
Class IV collagenase and soybean trypsin inhibitorand Insel [26]. Confluent monolayers of RPT cells were
were purchased from Life Technologies (Grand Island,incubated for 24 hours in DME/F12 medium containing
USA). Ang II, EGTA, EDTA, mepacrine, AACOCF3,0.5 mCi [3H]-AA/mL as well as the three growth supple- neomycin, W-7, AA, eicosatetraynoic acid (ETYA), in-
ments. The monolayers were then washed three times domethacin, econazole, BSA fraction IV, and ouabain
with Na1 uptake buffer and incubated at 378C for one were from Sigma Chemical Company (St. Louis, MO,
hour in uptake buffer containing specified agents at ap- USA). Fluo-3/AM was from Molecular Probes (Eugene,
propriate concentrations. In the experiments conducted OR, USA). 5,6-EET, 8,9-EET, and 11,12-EET were from
in the absence of Ca21, the primary RPT cells were Biomol (Plymouth Meeting, PA, USA), and PD123319
washed four times with Ca21-free Na1 uptake buffer was from Parke-Davis (Morris Plains, NY, USA). Losar-
and then preincubated with agonists in the same buffer, tan (DuP 753), 22Na1, 125I-Ang II, and [3H]-AA were
which further contained 1 mmol/L ethylene glycol-bis purchased from Dupont/NEN (Boston, MA, USA). All
(b-aminoethyl ether)-N,N,N9,N9-tetraacetic acid (EGTA) other reagents were of the highest purity commercially
for one hour prior to the incubation period. At the end available. Liquiscint was obtained from National Diag-
of the incubation period, the incubation medium was nostics (Parsippany, NY, USA). Iron oxide was prepared
removed by aspiration and transferred to ice-cold tubes by the method of Cook and Pickering [27]. Stock solu-
containing 100 mL each of 55 mmol/L EGTA, and ethyl- tions of 50 mg/mL iron oxide in 0.9% NaCl were steri-
enediaminetetraacetic acid (EDTA; each at a final con- lized and diluted with PBS prior to use.
centration of 5 mmol/L). The uptake buffer was then
Statistical analysiscentrifuged at 12,000 3 g to eliminate cell debris. To
determine the level of radioactivity in the supernatant, Results were expressed as means 6 SE. The difference
the samples were placed in scintillation vials containing between two mean values was analyzed by Students’ t-test.
scintillation fluid, and the radioactivity counted using Statistical significance was considered when P , 0.05.
a liquid scintillation counter (Beckman Co.). The cells
attached to each dish and were solubilized, and the radio-
RESULTSactivity was counted, as described previously in this arti-
Effects of Ang II on Na1 uptakecle for 22Na1 uptake studies. The quantity of [3H]-AA
released from each sample was standardized with respect The effect of Ang II on Na1 uptake in primary RPT
cells was examined as a function of the Ang II concentra-to protein. Average values for [3H]-AA release under
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tion. Primary RPT cells were incubated with Ang II at
concentrations ranging from 10213 to 1026 mol/L for four
hours, followed by an Na1 uptake period. Ang II was
observed to have a dose-dependent, biphasic effect on
Na1 uptake (Fig. 1A). While 10211 mol/L Ang II stimu-
lated Na1 uptake (20 6 5% increase vs. control, P ,
0.05), Ang II at dosages of 1029 mol/L and higher was
inhibitory (20 6 7% inhibition at 1029 mol/L Ang II vs.
control, P , 0.05). The inhibitory effect of 1029 mol/L
Ang II on Na1 uptake was examined as a function of
incubation time. A significant inhibitory effect of 1029
mol/L Ang II was first observed after two hours and
persisted over a six-hour time interval (Fig. 1B). These
inhibitory effects of Ang II on Na1 uptake were blocked
by 1027 mol/L actinomycin D (a transcription inhibitor)
and 4 3 1025 mol/L cycloheximide (a translation inhibi-
tor; data not shown).
To determine whether the observed stimulatory and
inhibitory effects of Ang II on Na1 uptake were due to
the interaction of Ang II with either the same or a differ-
ent set of Ang II receptors, Ang II binding studies were
conducted. The presence of either the Ang II receptor
subtype 1 or 2 (AT1 or AT2) was evaluated by the use
of either losartan or PD123319, which are antagonists
to the AT1 or the AT2 receptors, respectively. Figure 1C
shows that Ang II binding was significantly reduced by
losartan (1028 mol/L), both at 10211 mol/L Ang II (47 6
5%) and at 1029 mol/L Ang II (33 6 4% inhibition).
However, 1028 mol/L PD123319 did not have a significant
inhibitory effect. These results suggest that the AT1 re-
ceptor is the major Ang II receptor subtype in the pri-
mary RPT cell cultures. Thus, both the stimulatory and
the inhibitory effects of Ang II on Na1 uptake may
possibly be attributed to the interaction of Ang II with
the AT1 subtype of Ang II receptors. Indeed, losartan
(unlike PD123319) blocked the Ang II-induced inhibi-
tion of Na1 uptake (P , 0.05; Table 1). However, we
cannot exclude the possibility that a small number of
AT2 receptors is indeed present in primary RPT cells
and that these receptors play a role in Ang II signaling.
Role of PLA2 and AA in mediating the Ang II-
induced inhibition of Na1 uptake
The possibility that Ang II elicited its effects on trans-Fig. 1. Effect of angiotensin II (Ang II) on Na1 uptake and Ang II
port via the activation of PLA2 and the release of AAbinding by primary renal proximal tubule (RPT) cells. (A) Primary
RPT cells were treated with Ang II at a concentration ranging from was examined. The effects of increasing dosages of Ang II
10213 to 1026 mol/L for four hours at 378C, followed by a 22Na1 uptake on [3H]-AA release on primary RPT cells were examined.for 30 minutes (N 5 24). (B) The effect of 1029 mol/L Ang II (j) on
Figure 2A shows a significant, dose-dependent increaseNa1 uptake over time. RPT cells were incubated with 1029 mol/L Ang
II at times ranging from 30 minutes to 6 hours, and the effect of Ang in [3H]-AA release by primary RPT cells as a function
II on Na1 uptake was examined. (C ) Primary RPT cells were incubated
with Ang II (0, 10211, or 1029 mol/L) in the presence of 0.1 pmol/mL
[125I]-Ang II, and the level of [125I]-Ang II binding was determined as
described in the Methods section. In experiments with antagonist, the
culture was incubated for one hour with either losartan (1028 mol/L)
either eight (A), three (B), or five (C) independent experiments inor PD123319 (1028 mol/L) prior to the incubation with 125I-Ang II (N 5
triplicate. *P , 0.05 vs. control; **P , 0.01 vs. each unlabeled Ang II15). Symbols are: ( ) only 0.1 pmol/L 125I-Ang II; (h) 1 10211 mol/L
(10211 or 1029 mol/L); #P , 0.05 vs. unlabeled Ang II (10211 mol/L).Ang II; (j) 1 1029 mol/L Ang II. The results are means 6 SE for
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Table 1. Effects of angiotensin II (Ang II) receptor antagonists on
the Ang II-induced inhibition of Na1 uptake
Losartan PD123319
Incubation
condition Control nmol/mg protein
Control 42861 419623 446610
Ang II 33363a 427627b 342612a
Primary renal proximal tubule (RPT) cells were treated with either losartan
(1028 mol/L), PD123319 (1028 mol/L), or vehicle (control) for one hour prior to
incubation of Ang II (1029 mol/L) for four hours (N 5 12). Then, Na1 uptake
was performed for 30 minutes as described in the Methods section.
aP , 0.05 vs. control
bP , 0.05 vs. Ang II (1029 mol/L)
of increasing Ang II dosages, starting at an Ang II dosage
of 1029 mol/L and continuing through a dosage of 1027
mol/L. This Ang II concentration range corresponded
with the concentration range that inhibited Na1 uptake.
Figure 2B shows that the stimulatory effect of 1029
mol/L Ang II on [3H]-AA release was completely inhib-
ited by the AT1 receptor antagonist losartan, but not by
the AT2 receptor antagonist PD123319. These results
indicate that both the Ang II-induced activation of PLA2
and inhibition of Na1 uptake are initiated by the interac-
tion of Ang II with the AT1 subtype of Ang II receptors.
The possibility cannot be excluded, however, that the
AT2 subtype of the Ang II receptor is indeed involved
in negatively regulating the activity of PLA2. Indeed, in
Figure 2B, an increase in AA release is observed in the
presence of PD123319, which may be significant.
If the Ang II-induced inhibition of Na1 uptake is via
Fig. 2. Effect of Ang II on [3H]-arachidonic acid ([3H]-AA) release.the activation of PLA2, then possibly the AA released
(A) Effect of Ang II on [3H]-AA release by primary RPT cells wasfollowing PLA2 activation is responsible for this effect. examined. Primary RPT cells were incubated in culture medium con-
Consistent with this hypothesis, Figure 3 shows that ex- taining 0.5 mCi/mL [3H]-AA for 24 hours, followed by a one-hour
incubation period with Ang II at dosages ranging from 0 to 1027 mol/Logenous AA caused a significant, dosage-dependent de-
(N 5 9). Subsequently, the quantity of [3H]-AA released was measuredcrease in Na1 uptake. A significant inhibitory effect of and compared percentage-wise to the control level (obtained in cultures
exogenous AA was observed in the presence as well as not treated with Ang II). (B) Inhibition of Ang II-mediated AA release
by AA receptor antagonists. Primary RPT cells were incubated within the absence of 1029 mol/L Ang II (P , 0.05). Similarly,
[3H]-AA as described in (A). One hour prior to the treatment perioda significant inhibitory effect of Ang II was observed at with 1029 mol/L Ang II, a portion of the culture was treated with 1028
all of the AA concentrations studied. Thus, Ang II may mol/L losartan or 1028 mol/L PD123319 (N 5 9). Symbols are: ( ) 2
Ang II; (j) 1 1029 mol/L Ang II. The results are means 6 SE foralso decrease Na1 uptake by means of a mechanism
three independent experiments in triplicate. *P , 0.01 vs. control; **P ,independent of PLA2 activation and AA release. How- 0.05 vs. Ang II (1029 mol/L).
ever, Figure 3 (insert) shows that when the primary RPT
cells were treated with either of two different PLA2 in-
hibitors, mepacrine (1026 mol/L) or AACOCF3 (1026
epoxygenase), on the Ang II-mediated inhibition of Na1mol/L) [28, 29], the Ang II-induced inhibition of Na1
uptake. Figure 4A shows that when primary RPT cellsuptake was completely blocked.
were treated with either ETYA (1026 mol/L) or econa-
Role of AA metabolites in mediating the Ang II- zole (1026 mol/L), the Ang II-induced inhibition of Na1
induced inhibition of Na1 uptake uptake was significantly blocked (P , 0.05).
Based on the results in Figure 4A, we next evaluatedThe inhibitory effect of AA on Na1 uptake in primary
whether a cytochrome P450 epoxygenase metabolite(s)RPT cells can be explained either by direct effects of
of AA is responsible for causing the Ang II-mediatedAA on signaling or indirectly via an AA metabolite.
inhibition of Na1 uptake. The cytochrome P450 epoxy-Thus, we examined the effects of two inhibitors of AA
genase metabolites examined include 5,6-, 8,9-, andmetabolism, ETYA (a nonmetabolizable analogue of
AA) and econazole (an inhibitor of the cytochrome P450 11,12-EET (Fig. 4B). Of these metabolites, only 5,6-EET
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Fig. 3. Effect of AA on Na1 uptake. Primary
RPT cells were treated for four hours with
AA at dosages ranging from 0 to 1026 mol/L,
either alone (h) or in the presence (j) of 1029
mol/L Ang II. A 22Na1 uptake period followed
this incubation, as described in the Methods
section (N 5 12). The inset shows the influence
of the PLA2 inhibitors 1026 mol/L mepacrine
and 1026 mol/L AACOCF3 on Na1 uptake
both in cultures maintained in the absence (h)
and in the presence (j) of 1029 mol/L Ang II
(N 5 12). The results are means 6 SE for four
independent experiments in triplicate. *P ,
0.05 vs. control; ** P , 0.05 vs. Ang II alone.
significantly decreased Na1 uptake (60 6 6% of control, dose-dependent increase in [Ca21]i, as well as a significant
P , 0.05). These results thus indicate that 5,6-EET is increase in [3H]-AA release (Fig. 2A). Although a sig-
the main epoxide involved in mediating the inhibitory nificant increase in [Ca21]i was observed in the presence
effects of AA and of Ang II on Na1 uptake. Figure 4B of 10211 mol/L Ang II (107 6 1%; Table 2), presumably
also shows that indomethacin prevents the inhibitory this increase was not sufficient to stimulate [3H]-AA re-
effect of 5,6-EET on Na1 uptake, suggesting that the lease (Fig. 4A). The effect of Ang II on [Ca21]i was
effect of 5,6-EET is cyclooxygenase dependent (Fig. 4B). reduced in the presence of EGTA, indicating a depen-
Figure 4C shows that the magnitude of the inhibition dence on exogenous Ca21. However, as Ang II still
of Na1 uptake caused by 5,6-EET was similar to the caused a significant increase in [Ca21]i in the presence
level of inhibition of Na1 uptake that was caused by 1029 of EGTA, changes in intracellular calcium pools indepen-
mol/L Ang II alone. Significantly more inhibition of Na1 dent of exogenous Ca21 nonetheless may be occurring.
uptake was obtained in the presence of 1029 mol/L Ang II We then evaluated whether the Ang II-mediated
and 1026 mol/L 5,6-EET in combination than with 1029 [3H]-AA release was calcium dependent. Figure 5A shows
mol/L Ang II alone. Presumably, this observation can that the Ang II-mediated [3H]-AA release was increased
be explained if 1029 mol/L Ang II is below the Ang II significantly in the presence of 1 mmol/L CaCl2 and com-concentration causing maximal inhibition of Na1 uptake pletely blocked by two different PLA2 inhibitors, mepa-(Fig. 2A). However, the possibility cannot be excluded
crine and AACOCF3. Because of the possible involve-that other signaling mechanisms are involved in mediat-
ment of calcium-mediated signaling pathways, the effectsing the inhibitory effects of Ang II on Na1 uptake.
of a phospholipase C (PLC) inhibitor, neomycin, andFigure 4C also shows that 5,6-EET also inhibited the
a calmodulin-dependent protein kinase inhibitor, W-7,Na1 uptake, which occurred in the presence of an Ang II
were also examined. Figure 5B shows that neomycindosage that was stimulatory to Na1 uptake (10211 mol/L).
and W-7 both completely blocked the Ang II-mediatedIn the presence of 10211 mol/L Ang II, 5,6-EET com-
release of [3H]-AA (P , 0.01). Thus, these results indi-pletely blocked the stimulatory effect of 10211 mol/L Ang
cate that the Ang II-mediated [3H]-AA release may beII on Na1 uptake. In the presence of 1029 mol/L Ang II,
attributed to Ca21-dependent PLA2, in addition to other5,6-EET reduced Na1 uptake below the level observed in
signaling pathways, and enzymes such as PLC.the presence of 1029 mol/L Ang II alone.
To examine the involvement of Ca21-dependent path-
Role of Ca21 in Ang II-mediated AA release ways further, the effect of neomycin and W-7 on the
Ang II-mediated inhibition of Na1 uptake was examinedThe effects of increasing dosages of Ang II on intracel-
(Fig. 6). Consistent with the involvement of a Ca21-depen-lular Ca21 ([Ca21]i) were examined by means of confocal
dent PLC, both W-7 and neomycin blocked the inhibitoryimaging. Table 2 shows that when the Ang II dosage
was raised above 10211 mol/L, Ang II caused a significant effect of Ang II on 22Na1 uptake.
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Table 2. Calcium transients in response to Ang II









1029 1 EGTA 124 64
Values are means 6 SE of 30 separate experiments performed on 10 different
cultures. Fluo-3/AM loaded proximal tubule cells incubated in a bath solution
containing 1 mmol/L CaCl2 were challenged with the indicated concentration of
Ang II. In the experiments of EGTA (1 mmol/L; Methods section), the Fluo-
3/AM loaded primary renal proximal tubule (RPT) cells were scanned by confo-
cal microscopy under the treatment of only 1029 mol/L Ang II. Data were
analyzed by Microsoft Excel and are expressed as the % control of the fluores-
cence baseline.
DISCUSSION
The RPT is a primary site in the nephron at which
Ang II exerts its regulatory effects on salt and water
transport [30]. For this reason, considerable attention
has been devoted toward defining the signaling pathways
by which Ang II exerts its effects on this nephron seg-
ment [31, 32]. The regulatory effects of Ang II have been
primarily attributed to its effects on the activity of the
renal Na1/H1 antiport system, as exemplified by studies
with isolated rat RPT cells [8] and the opossum kidney
(OK) cell line [9]. The mechanisms by which Ang II
exerts its effects on the Na1/H1 antiport system were
examined in a primary rabbit RPT (primary RPT) cell
culture system. A broad Ang II dosage range was exam-
ined initially, as plasma Ang II concentrations have been
estimated to range from 10211 mol/L to 3 3 1029 mol/L
(under conditions of sodium depletion) [33]. Consistent
with previous studies, a dose-dependent biphasic effect
of Ang II on the activity of the Na1/H1 antiport system
was observed. Low Ang II dosages stimulated, whereas
high dosages inhibited the activity of the Na1/H1 anti-
port system in the primary cultures.
Fig. 4. Influence of cytochrome P450 epoxygenase metabolites on The signaling mechanisms underlying the inhibitory
22Na1 uptake. (A) The effect of ETYA and econazole on 22Na1 uptake effects of Ang II on Na1 uptake were examined in detail.was examined in primary RPT cells both in the presence (j) and in
The involvement of PLA2 in mediating the inhibitorythe absence (h) of 1029 mol/L Ang II. The primary RPT cells were
pretreated for one hour with either 1026 mol/L ETYA or 1026 mol/L effects of Ang II on Na1 uptake in the primary RPT
econazole prior to the four-hour treatment with 1029 mol/L Ang II cell cultures was indicated by the similarity in the dose-(N 5 12). Subsequently, a 22Na1 uptake period of 30 minutes followed,
response curves obtained for Ang II-mediated [3H]-AAas described in the Methods section. (B) To examine the effect of cyto-
chrome P450 epoxygenase products on 22Na1 uptake in primary RPT release and Ang II-induced inhibition of Na1 uptake.
cells, the primary RPT cells were preincubated for four hours with
Exogenous AA not only inhibited Na1 uptake in primaryeither 1026 mol/L 5,6-EET, 1026 mol/L 8,9-EET, 1026 mol/L 11,12-EET,
or 1026 mol/L indomethacin in combination with 5,6-EET (N 5 12). RPT cell cultures, but mepacrine, a specific inhibitor of
(C ) To examine the effect of 5,6-EET on Ang II-induced stimulation PLA2, suppressed the Ang II-induced inhibition of Na1of Na1 uptake, RPT cells were incubated either in the presence or in
uptake. Finally, both the Ang II-mediated [3H]-AA re-the absence of 1026 mol/L 5,6-EET for four hours. During the four-
hour incubation in the two conditions, RPT cells were also maintained lease and the Ang II-induced inhibition of Na1 uptake
either in the absence (h) or in the presence of Ang II [either 10211 ( ) were blocked by the AT1-specific antagonist losartan,or 1029 (j) mol/L]. Results are means 6 SE for four independent
rather than the AT2-specific antagonist PD123319. Whileexperiments in triplicate. *P , 0.05 vs. control; **P , 0.05 vs. Ang II
or 5,6-EET. AA inhibited Na1 uptake, further investigations indi-
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Fig. 6. Effect of neomycin and W-7 on Ang II-induced inhibition of
Na1 uptake. Primary RPT cells were incubated with 1024 mol/L neomy-
cin and 1024 mol/L W-7 for one hour prior to treatment with 1029 mol/L
Ang II. Then, Na1 uptake was conducted (N 5 9). Symbols are: (h)
no Ang II treatment; (j) treatment with 1029 mol/L Ang II. Results are
means 6 SE for three independent experiments in triplicate. *P , 0.01
vs. control; **P , 0.05 vs. Ang II (1029 mol/L).
Na1/H1 antiport system. In addition, at the higher Ang II
dosages studied, evidence was obtained for the activation
of PLA2 and the release of AA. 5,6-EET, a metabolite
of AA, was shown to have an inhibitory effect on the
activity of the Na1/H1 antiport system in both experi-
mental systems. Thus, previous conflicting observations
are not necessarily explained by species specificity (rat
vs. rabbit) as previously proposed.
Romero et al similarly reported an inhibitory effect
Fig. 5. Effect of calcium on Ang II-mediated AA release. Primary RPT of 5,6-EET on the apical-to-basolateral Na1 flux across
cells were incubated for 24 hours with 0.5 mCi/mL [3H]-AA, as described monolayers of their primary rabbit kidney proximal tu-in Figure 4. Primary RPT cells were incubated with mepacrine (MEPA
bule cells [34]. Their experimental results suggested that1026 mol/L) or AACOCF3 (1026 mol/L). (A) To examine the effect of
exogenous calcium on [3H]-AA for one hour prior to the one-hour the inhibitory effect of 5,6-EET on such Na1 fluxes was
incubation with agonist (Methods section). Symbols are: (h) Ca21-free;
due to a partial inhibition of Na,K-ATPase. Presumably,(j) 1 mmol/L CaCl2. (B) The effect of neomycin and W-7 on [3H]-AA
release by primary RPT cells was examined both in the presence (j) a decrease in the rate of Na1 efflux from the cells via the
and in the absence (h) of 1029 mol/L Ang II (N 5 9). The results are Na,K-ATPase could result in a decrease in the activity of
means 6 SE for three independent experiments in triplicate. *P , 0.05
the Na1/H1 antiport system. However, in our investiga-vs. Ang II (1029 mol/L).
tions in which the activity of the Na1/H1 antiport system
was examined while the Na,K-ATPase was inhibited by
ouabain, the possibility of such an indirect effect wascated that AA actually acted indirectly, as a consequence
eliminated.of its metabolism to 5,6-EET by cytochrome P450 epoxy-
Although Jacobs and Douglas similarly studied Ang IIgenase. The involvement of calcium in the Ang II-medi-
signaling with rabbit kidney proximal tubule cell cul-ated inhibition of Na1 uptake was also suggested in our
tures, our results differ from those obtained by theseexperimental studies.
investigators in several respects [12]. Whereas JacobsOur results are consistent with the recent studies by
and Douglas reported that [Sar1]-Ang II concentrationsHouillier et al using purified rat RPTs, despite several
of 1026 mol/L or higher were required in order to stimu-procedural differences [8]. We determined the activity
late [3H]-AA release, we obtained such a response onlyof the Na1/H1 antiport system by means of 22Na1 uptake
with 1029 mol/L Ang II [12]. Also, unlike our observations,determinations rather than by means of intracellular pH
Jacobs and Douglas found that [Sar1]-Ang II–stimulatedmeasurements, as conducted by Houillier et al [8]. In
[3H]-AA release was inhibited by an AT2-selective antag-addition, we used longer incubation times with Ang II
onist (PD123319), rather than by an AT1-selective antag-than Houillier et al [8]. Nevertheless, we observed a
similar biphasic effect of Ang II on the activity of the onist (losartan) [12]. Therefore, they proposed an AT2
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Fig. 7. Model for regulation of Na1 uptake
by high dose of Ang II in primary rabbit kidney
proximal tubule cell. Ang II binding to its re-
ceptor is coupled to the G protein, which leads
to the activation of PLA2 and production of
arachidonic acid metabolites, and subsequently
inhibition of Na1 uptake. Ang II also activates
PLC to generate IP3 and DAG. In turn, IP3
increases the release of Ca21 from intracellular
storage pool and DAG activates protein kinase
C, which inhibits the Na1 uptake. Abbrevia-
tions are: Ang II, angiotensin II; R, receptor;
G, GTP binding protein; PLC, phospholipase
C; PLA2, phospholipase A2; PIP2, phosphati-
dylinositol-4,5-biphosphate; AA, arachidonic
acid; IP3, 1,4,5-inositol-triphosphate; DAG,
diacylglycerol; PKC, protein kinase C; ER,
endoplasmic reticulum; 5,6-EET, 5,6 epoxy-
eicosatrienoic acids. Solid line denotes the
proposed pathway and the dotted line is the
suspected pathway.
receptors’ involvement rather than the involvement of ever, in our primary RPT cultures, only the AT1 subtype
of Ang II receptors was observed. Thus, we have attrib-AT1 receptors that we observed in our primary RPT cells.
These differences between the two reports may be due uted both the stimulatory and inhibitory effects of Ang
II to different classes of signaling events initiated by theto differences in culture conditions. In our investigations,
only primary rabbit kidney cells maintained in medium interaction of Ang II with one subtype of Ang II recep-
tor. Studies with the LLC-PK1 cell line, transfected withwith only three growth supplements (insulin, transferrin,
and hydrocortisone) were used. However, Jacobs and plasmid cDNA encoding the rabbit AT1 receptor [23],
are consistent with our observations. The results of theseDouglas employed first passage rabbit kidney proximal
tubule cells grown in medium containing serum in addi- studies with such transfected LLC-PK1 cells showed that
the interaction of Ang II with AT1 receptors similarlytion to these three growth supplements. For these rea-
sons, Jacobs and Douglas may have been culturing a stimulated [3H]-AA release, indicating the activation of
PLA2.different cell type, and that cell type may have been
influenced by growth factors unavailable to our primary While Ang II activation of PLA2 (and AA release)
may be a central part of signaling by high dosages ofRPT cells [35].
Our results are consistent with recent studies on two Ang II, the subsequent metabolism of AA is apparently
also an integral part of the signaling mechanism. Al-different sublines of the opossum kidney (OK) cell line.
The two sublines possess different subtypes of Ang II though AA can possibly be metabolized by three differ-
ent enzymatic pathways (including a cyclooxygenase-, areceptors [9]. 22Na1 uptake studies conducted with these
two different classes of OK cells indicated that Ang II lipoxygenase-, and a cytochrome P450-dependent epoxy-
genase-mediated pathway [36]), primarily cytochromereversed the PTH-mediated inhibition of the Na1/H1
antiport system in OK-VD cells, which possess AT2 re- P450 epoxygenase activity is localized in the RPT [36, 37].
Although cytochrome P450 epoxygenase activity is notceptors. This action of Ang II was attributed to the inhi-
bition of adenylate cyclase through a pertussis toxin- necessarily retained in culture (as exemplified by studies
with cultures derived from the rabbit renal medullarysensitive Gi protein [9]. In OK-RR cells, which possess
AT1 receptors, inhibition of the Na1/H1 antiport system thick ascending limb [36]), this enzymatic activity was
detected by Romero et al in primary cultures derivedby high dosages of Ang II was observed, but could not be
attributed to effects on adenylate cyclase. These results from microdissected rabbit RPTs [34]. These investiga-
tors found that the major metabolic product of AA bysuggest that the different effects of Ang II at high and
low dosages could be explained by the interaction of the cytochrome P450 epoxygenase present in these cul-
tures was 5,6-EET, consistent with our results.Ang II with different classes of Ang II receptors, which
act via two different classes of signaling pathways. How- A number of different EETs are generated by cyto-
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chrome P450 epoxygenase, which can, in turn, be converted product of PLA2-derived AA (metabolized via a cyto-
to other metabolic products, such as dihydroxyeicosatri- chrome P450 pathway), appears to mediate the Ang II-
enoic acids (DHETs) [36]. Indeed, further metabolism induced inhibition of Na1 uptake. In addition, a PLC/
of 5,6-EET to a prostaglandin analogue by cyclooxygen- PKC signaling pathway is also involved in mediating the
ase has been reported in the rabbit kidney [38], which effect of Ang II. The initial activation of PLA2 by Ang
was a metabolic event deemed necessary for the reported II involves the interaction of Ang II with the AT1 subtype
vasoactive effects of 5,6-EET in this tissue [38]. of Ang II receptors and occurs in a calcium-dependent
A similar metabolism of 5,6-EET by cyclooxygenase manner. Thus, the Ang II-mediated signaling pathway
may be occurring in our primary RPT cells, as we ob- involving PLA2 interacts with a calcium signaling path-
served that indomethacin, a cyclooxygenase inhibitor, way(s), which is also activated by Ang II. The cell culture
abolished the effects of 5,6-EET on Na1 uptake in this results not only confirm the results of previous studies
culture system. Admittedly, the metabolism of 5,6-EET with intact RPTs, but also indicate that the primary RPT
by cyclooxygenase may possibly be the consequence of cell culture system is appropriate for mechanistic studies
a phenotypic change that occurred in the primary RPT concerning Ang II-mediated signaling pathways. The in
cell cultures. However, our Western analyses indicate that vitro studies provide evidence regarding the involvement
the levels of cyclooxygenase I and cyclooxygenase II do of Ca21-mediated signaling pathways in Ang II action.
not differ significantly in isolated rabbit kidney proximal
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